Helpline Tollfree +1.800.650.8239 info@clearsynth.com

OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005

We speak your language 

Prucalopride

API Standards
CAT No.
:
CS-O-30738

CAS No.

:

179474-81-8

Molecular Weight

:

367.87

Molecular Formula

:

C18H2ClN3O3

Purity

:

>98%

Inventory Status:

:

Available for Immediate Shipment
 



Money
Back Guarantee

48 Hours Delivery
(For In-stock compounds)

Online
Purchase Protection


Useful information

"Prucalopride (brand name Resolor, developed by Johnson & Johnson and licensed to Movetis) is a drug acting as a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements. Prucalopride was approved for use in Europe in 2009, in Canada (named Resotran) on December 7, 2011 and in Israel in 2014 but it has not been approved by the Food and Drug Administration for use in the United States. The drug has also been tested for the treatment of chronic intestinal pseudo-obstruction.",""



Product Application Notes

Prucalopride is a drug acting as a selective, high affinity 5-HT4 receptor agonist which targets the impaired motility associated with chronic constipation, thus normalising bowel movements.



Synonyms

4-aminoridin-4- yl]-2,3-dihydro-1-benzofuran-7carboxamide



References

Schuurkes, J. A. (2001); Vandeplassche, L. (2012



MSDS



Have any questions ?

We normally respond within 8 hours.

Subject :

  Stock Status

  Bulk Pricing

  Custom QTY Quote

  Request MSDS

  Request COA

  Other






Page info:

This page contains information about Prucalopride Cas # 179474-81-8 and its API Standards.

Prucalopride Prucalopride Worldwide Suppliers of Prucalopride API Standards Clearsynth 179474-81-8

Product rating: 9 Prucalopride based on 20 ratings

  1. API Standards

  2. Prucalopride



Keywords

Keywords: API Standards 4-aminoridin-4- yl]-2,3-dihydro-1-benzofuran-7carboxamide CS-O-30738 Prucalopride Prucalopride 179474-81-8 367.87 C18H2ClN3O3
Internal standard, Internal standard Prucalopride, HPLC-MS method validation, HPLC-MS method validation Prucalopride, LC-MS-MS method validation, LC-MS-MS method validation Prucalopride, Deuterated internal standard, Deuterated internal standard Prucalopride, Deuterated Prucalopride, Deuterium labeled Prucalopride, Quantitative bioanalytical methods, Quantitative bioanalytical methods Prucalopride, Blood samples Prucalopride, Blood concentrations, Heavy drugs, Analysis, Analysis Prucalopride, Clinical diagnostic, Clinical diagnostic Prucalopride, Dosing Prucalopride, Analytical method development, Internal standard method.



Related result for 'Prucalopride'

- Prucalopride : API Standards

- Prucalopride : Stable Isotopes

- Prucalopride : Metabolites

- Prucalopride : Intermediates



QUICK ENQUIRY

Specific product requirements



Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(






NORTH AMERICAN SALES AND R&D CENTRE

CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060

ASIA R&D CENTRE

CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
Hyderabad- 500076,
Telangana, India.
T : +91-40-27155481

ASIA OFFICE

CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
India
T : +91-22-45045945